5-129461123-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_133638.6(ADAMTS19):c.113G>T(p.Arg38Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000789 in 1,267,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133638.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS19 | NM_133638.6 | c.113G>T | p.Arg38Leu | missense_variant | 2/23 | ENST00000274487.9 | NP_598377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS19 | ENST00000274487.9 | c.113G>T | p.Arg38Leu | missense_variant | 2/23 | 1 | NM_133638.6 | ENSP00000274487 | P1 | |
ADAMTS19 | ENST00000505791.5 | c.91+641G>T | intron_variant, NMD_transcript_variant | 3 | ENSP00000423537 | |||||
ADAMTS19-AS1 | ENST00000661962.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.89e-7 AC: 1AN: 1267926Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 623852
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.95G>T (p.R32L) alteration is located in exon 2 (coding exon 2) of the ADAMTS19 gene. This alteration results from a G to T substitution at nucleotide position 95, causing the arginine (R) at amino acid position 32 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at